尤瑞克林注射液治疗急性脑梗死的疗效及安全性  

Effect and safety of urinary kallidinogenase injection in the treatment of acute cerebral infarction

作　　者：王琪[1] 魏俊[1] 李小琴[1] 

机构地区：[1]宜宾市第一人民医院神经内科,四川宜宾644000

出　　处：《新乡医学院学报》2016年第11期980-982,共3页Journal of Xinxiang Medical University

摘　　要：目的观察尤瑞克林注射液治疗急性脑梗死(ACI)的疗效及安全性。方法选取2013年1月至2015年1月宜宾市第一人民医院收治的ACI患者110例,根据治疗方法分为观察组和对照组,每组55例。对照组患者给予降血脂、控制血压、控制血糖、抗血小板、营养神经、改善脑血液循环、吸氧等常规治疗,观察组患者在常规治疗基础上给予尤瑞克林治疗,比较2组患者的治疗效果,并观察尤瑞克林注射液的用药安全性。结果治疗前2组患者国立卫生研究院卒中量表(NIHSS)、Barthel指数量表(BI)评分比较差异无统计学意义(P>0.05)。治疗结束后2周,2组患者NIHSS评分显著低于治疗前(P<0.05),BI评分显著高于治疗前(P<0.05)。治疗结束后3个月,2组患者BI评分显著高于治疗前和治疗结束后2周(P<0.05)。2组患者治疗结束后2周椎基底动脉收缩峰期血流速度均显著高于治疗前和治疗结束时(P<0.05);观察组显著高于对照组(P<0.05)。观察组患者治疗过程中未发现与尤瑞克林明显有关的不良反应。结论尤瑞克林注射液能够有效改善ACI患者的神经功能,提高生活质量,且安全性较好。Objective To observe the effect and safety of urinary kallidinogenase injection in the treatment of acute cerebral infarction（ACI）. Methods A total of 110 patients with ACI were selected in the First People＇s Hospital of Yibin City from January 2013 to January 2015. The patients were divided into observation group and control group according to thera- peutic method,55 cases in each group. The patients in control group were treated with conventional therapy such as lowering blood fat, controlling blood pressure and blood glucose, antiplatelet, trophic nerve, improving cerebral blood circulation, oxygen inhalation and so on. The patients in observation group were treated with urinary kallidinogenase on the basis of conventional treatment. The effect was compared between the two groups, and the safety of urinary kallidinogenase was observed. Results There was no significant difference in the national institute of health stroke scale（NIHSS） and Barthel index（BI） score between the two groups before treatment（P 〉 0.05）. Two weeks after treatment, the NIHSS score was significantly lower than that before treatment（ P 〈 0.05 ）, and the BI score was significantly higher than that before treatment in the two groups （P 〈 0. 05 ）. Three months after treatment,the BI score was significantly higher than that before treatment and two weeks after treatment in the two groups （ P 〈 0.05 ）. Two weeks after treatment, the peak blood flow velocity of vertebral basilar artery was significantly higher than that before treatment and at the end of treatment in the two groups （ P 〈 0.05 ）, and the peak blood flow velocity of vertebral basilar artery in observation group was significantly higher than that in control group（P 〈 0.05 ）. There was no significant urinary kallidinogenase related adverse reaction during the treatment in observation group. Conclusion Urinary kallidinogenase injection can effectively improve the neurological function,improve the quality of life of ACI patients, and t

关 键 词：尤瑞克林 脑梗死 安全性 不良反应 

分 类 号：R743.3[医药卫生—神经病学与精神病学]